However, higher CYP2C9 and CYP2D6 activity has most probably no significant role in NAFLD progression because these CYP isoforms do not produce ROS during their catalytic cycles, in contrast to CYP2E1 [18]. Here, CYP2E1 is linked to metabolic dysfunction-associated steatotic liver disease.